Angiodysplasia future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
In a study, significantly lower levels of Angiopoietin-1 (Ang-1) and [[TNF-α]] were found in patients with small bowel angiodysplasia as compared to the [[control group]]. Despite similar progress in some other studies, the use of chemical markers of angiogenesis as diagnostic tool for angiodysplasia is still at an early stage and would require further research into this area.
In a study, significantly lower levels of Angiopoietin-1 (Ang-1) and [[TNF-α]] were found in patients with small bowel angiodysplasia as compared to the [[control group]].<ref name="pmid28868182">{{cite journal| author=Holleran G, Hussey M, Smith S, McNamara D| title=Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia. | journal=World J Gastrointest Pathophysiol | year= 2017 | volume= 8 | issue= 3 | pages= 127-132 | pmid=28868182 | doi=10.4291/wjgp.v8.i3.127 | pmc=5561433 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28868182  }} </ref> Despite similar progress in some other studies, the use of chemical markers of angiogenesis as diagnostic tool for angiodysplasia is still at an early stage and would require further research into this area.


Further insight into the [[pathogenesis]] of angiodysplasia is required for better diagnostic and therapeutic options of this condition.
Further insight into the [[pathogenesis]] of angiodysplasia is required for better diagnostic and therapeutic options of this condition.<ref name="pmid31210709">{{cite journal| author=García-Compeán D, Del Cueto-Aguilera ÁN, Jiménez-Rodríguez AR, González-González JA, Maldonado-Garza HJ| title=Diagnostic and therapeutic challenges of gastrointestinal angiodysplasias: A critical review and view points. | journal=World J Gastroenterol | year= 2019 | volume= 25 | issue= 21 | pages= 2549-2564 | pmid=31210709 | doi=10.3748/wjg.v25.i21.2549 | pmc=6558444 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31210709  }} </ref>


==References==
==References==
<references />
{{Reflist|2}}
 
[[Category:Gastroenterology]]
 
{{WS}}
{{WH}}

Revision as of 07:58, 15 October 2021

In a study, significantly lower levels of Angiopoietin-1 (Ang-1) and TNF-α were found in patients with small bowel angiodysplasia as compared to the control group.[1] Despite similar progress in some other studies, the use of chemical markers of angiogenesis as diagnostic tool for angiodysplasia is still at an early stage and would require further research into this area.

Further insight into the pathogenesis of angiodysplasia is required for better diagnostic and therapeutic options of this condition.[2]

References

  1. ↑ Holleran G, Hussey M, Smith S, McNamara D (2017). "Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia". World J Gastrointest Pathophysiol. 8 (3): 127–132. doi:10.4291/wjgp.v8.i3.127. PMC 5561433. PMID 28868182.
  2. ↑ García-Compeán D, Del Cueto-Aguilera ÁN, Jiménez-Rodríguez AR, González-González JA, Maldonado-Garza HJ (2019). "Diagnostic and therapeutic challenges of gastrointestinal angiodysplasias: A critical review and view points". World J Gastroenterol. 25 (21): 2549–2564. doi:10.3748/wjg.v25.i21.2549. PMC 6558444 Check |pmc= value (help). PMID 31210709.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Angiodysplasia_future_or_investigational_therapies&oldid=1715429"